13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Horizon Scanning for Translational Genomic Research Beyond Bench to Bedside

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The dizzying pace of genomic discoveries is leading to an increasing number of clinical applications. However, very little translational research is ongoing beyond Bench to Bedside to assess validity, utility, implementation and outcomes of such applications. Here we report cross sectional results of ongoing horizon scanning of translational genomic research conducted between May 16, 2012 and May 15, 2013. Based on a weekly, systematic query of PubMed, we created a curated set of 505 beyond bench-to-bedside research publications, including 312 original research articles, 123 systematic and other reviews, 38 clinical guidelines, policies and recommendations, and 32 papers describing tools, decision support and educational materials. Most papers (62%) addressed a specific genomic test or other health application; almost half of these (n=180) were related to cancer. We estimate that these publications account for 0.5% of reported human genomics and genetics research during the same time. These data provide baseline information to track the evolving knowledge base and gaps in genomic medicine. Continuous horizon scanning is crucial for an evidence-based translation of genomic discoveries into improved health care and disease prevention.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Charting a course for genomic medicine from base pairs to bedside.

          There has been much progress in genomics in the ten years since a draft sequence of the human genome was published. Opportunities for understanding health and disease are now unprecedented, as advances in genomics are harnessed to obtain robust foundational knowledge about the structure and function of the human genome and about the genetic contributions to human health and disease. Here we articulate a 2011 vision for the future of genomics research and describe the path towards an era of genomic medicine.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Implementing genomic medicine in the clinic: the future is here

            Although the potential for genomics to contribute to clinical care has long been anticipated, the pace of defining the risks and benefits of incorporating genomic findings into medical practice has been relatively slow. Several institutions have recently begun genomic medicine programs, encountering many of the same obstacles and developing the same solutions, often independently. Recognizing that successful early experiences can inform subsequent efforts, the National Human Genome Research Institute brought together a number of these groups to describe their ongoing projects and challenges, identify common infrastructure and research needs, and outline an implementation framework for investigating and introducing similar programs elsewhere. Chief among the challenges were limited evidence and consensus on which genomic variants were medically relevant; lack of reimbursement for genomically driven interventions; and burden to patients and clinicians of assaying, reporting, intervening, and following up genomic findings. Key infrastructure needs included an openly accessible knowledge base capturing sequence variants and their phenotypic associations and a framework for defining and cataloging clinically actionable variants. Multiple institutions are actively engaged in using genomic information in clinical care. Much of this work is being done in isolation and would benefit from more structured collaboration and sharing of best practices. Genet Med 2013:15(4):258–267
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.

              Cholesterol reduction from statin therapy has been one of the greatest public health successes in modern medicine. Simvastatin is among the most commonly used prescription medications. A non-synonymous coding single-nucleotide polymorphism (SNP), rs4149056, in SLCO1B1 markedly increases systemic exposure to simvastatin and the risk of muscle toxicity. This guideline explores the relationship between rs4149056 (c.521T>C, p.V174A) and clinical outcome for all statins. The strength of the evidence is high for myopathy with simvastatin. We limit our recommendations accordingly.
                Bookmark

                Author and article information

                Journal
                9815831
                22061
                Genet Med
                Genet. Med.
                Genetics in medicine : official journal of the American College of Medical Genetics
                1098-3600
                1530-0366
                21 May 2014
                09 January 2014
                July 2014
                01 July 2015
                : 16
                : 7
                : 535-538
                Affiliations
                [1 ]Kelly Services, Troy, Michigan, USA
                [2 ]Epidemiology and Genomics Research Program, National Cancer Institute, Bethesda, Maryland, USA
                [3 ]Office of Public Health Genomics, Centers for Disease Control and Prevention
                [4 ]McKing Consulting Corporation, Atlanta, Georgia, USA
                [5 ]Cadence Group, Atlanta, Georgia, USA
                Author notes
                Corresponding author: Mindy Clyne, National Cancer Institute, Epidemiology and Genomics Research Program, 9609 Medical Center Drive, MSC 9763, Bethesda, MD 20892, Phone: (240) 276-6936, Fax: (404) 498-0140, mindy.clyne@ 123456nih.gov
                Article
                NIHMS571299
                10.1038/gim.2013.184
                4079725
                24406461
                7bf1c5dd-8256-4e5f-b553-c1265c195ebb
                History
                Categories
                Article

                Genetics
                genomic medicine,public health,surveillance,translational research
                Genetics
                genomic medicine, public health, surveillance, translational research

                Comments

                Comment on this article